# EDGAR Filing Document

**Accession Number:** 0001720420
**File Stem:** 0001720420-25-000053
**Filing Date:** 2025-12
**Character Count:** 22456
**Document Hash:** 6888bf0bd47d4cee370a28e3322eb5da
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001720420-25-000053.hdr.sgml**: 20251219

**ACCESSION NUMBER**: 0001720420-25-000053

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 6

**REFERENCES 429**: 333-242044

**REFERENCES 429**: 333-263228

**FILED AS OF DATE**: 20251219

**DATE AS OF CHANGE**: 20251219

**EFFECTIVENESS DATE**: 20251219

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IBEX Ltd
- **CENTRAL INDEX KEY:** 0001720420
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D0
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-292290
- **FILM NUMBER:** 251587796

**BUSINESS ADDRESS:**
- **STREET 1:** 1717 PENNSYLVANIA AVENUE NW
- **STREET 2:** SUITE 825
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20006
- **BUSINESS PHONE:** (202)580-6200

**MAIL ADDRESS:**
- **STREET 1:** 1717 PENNSYLVANIA AVENUE NW
- **STREET 2:** SUITE 825
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20006

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IBEX Holdings Ltd
- **DATE OF NAME CHANGE:** 20171023

**As filed with the Securities and Exchange Commission on December 19, 2025**

**Registration No. 333-**

**UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION<br>WASHINGTON, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933**

---

| | |
|:---|:---|
| **IBEX LIMITED** | **IBEX LIMITED** |
| (Exact name of registrant as specified in its charter) | (Exact name of registrant as specified in its charter) |
| **Bermuda** | **00-0000000** |
| (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer Identification No.) |
| **1717 Pennsylvania Avenue NW, Suite 825**<br>**Washington, District of Columbia**  | **20006** |
| (Address of Principal Executive Offices) | (Zip Code) |
| **IBEX LIMITED AMENDED AND RESTATED**<br>**2020 LONG-TERM INCENTIVE PLAN** | **IBEX LIMITED AMENDED AND RESTATED**<br>**2020 LONG-TERM INCENTIVE PLAN** |
| (Full title of the plan) | (Full title of the plan) |
| <br>**Robert Dechant, Chief Executive Officer**<br>**IBEX Limited**<br>**1717 Pennsylvania Avenue NW, Suite 825**<br>**Washington, DC 20006**<br>**(202) 580-6200** | **David C. Lee<br>Jones Day<br>3161 Michelson Drive, Suite 800<br>Irvine, CA 92612<br>(949) 553-7570** |
| (Name, address, telephone number,<br>including area code, of agent for service) | (Copy to) |

---

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ◻ Accelerated filer 🗹 Non-accelerated filer ◻ Smaller reporting company 🗹 Emerging growth company 🗹

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. □

------

**EXPLANATORY NOTE**

This Registration Statement on Form S-8 (this "Registration Statement") relates to the registration of an additional 650,000 shares (the "Shares") of the common shares, par value $0.000111650536 per share, of IBEX Limited (the "Registrant"). The Shares are securities of the same class and relate to the same employee benefit plan, the IBEX Limited Amended and Restated 2020 Long-Term Incentive Plan, which was amended and restated effective as of December 5, 2025, as those registered pursuant to the Registrant's registration statements on <u>[Form S-8 (File No. 333-242044)](https://www.sec.gov/Archives/edgar/data/1720420/000114036120017744/nt10006851x13_s8.htm)</u> and <u>[Form S-8 (File No. 333-263228)](https://www.sec.gov/Archives/edgar/data/1720420/000110465922029333/tm224577d1_s8.htm)</u>, previously filed with the U.S. Securities and Exchange Commission (the "Commission") on August 7, 2020 and March 2, 2022 (the "Prior Registration Statements"). In accordance with General Instruction E of Form S-8, the contents of the Prior Registration Statements are incorporated herein by reference and the information required by Part II is omitted, except as supplemented by the new information set forth below.

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

---

| | |
|:---|:---|
| **Item 3.** | **Incorporation of Documents by Reference.** |

---

The following documents previously filed by the Registrant with the Commission are incorporated herein by reference and shall be deemed to be a part hereof:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[(1) The Registrant's Annual Report on Form 10-K (File No. 001-38442), for the fiscal year ended June 30, 2025, filed with the Commission on September 11, 2025.](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001720420/000172042025000027/ibex-20250630.htm)</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[(2) The Registrant's Quarterly Report on Form 10-Q (File No. 001-38442) for the quarterly period ended September 30, 2025, filed with the Commission on November 6, 2025.](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001720420/000172042025000040/ibex-20250930.htm)</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) The Registrant's Current Report on Form 8-K (File No. 001-38442) filed with the Commission on <u>[November 24, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001720420/000172042025000042/ibex-20251120.htm)</u> and <u>[December 10, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001720420/000172042025000050/ibex-20251204.htm)</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) The description of the Registrant's common shares contained in the Registration Statement on <u>[Form 8-A (File No. 001-38442)](https://www.sec.gov/Archives/edgar/data/1720420/000114036120017430/nt10006851x12_8a12b.htm)</u>, filed with the Commission on August 4, 2020, as updated by the description of the Registrant's common shares contained in <u>[Exhibit 4.1](https://www.sec.gov/Archives/edgar/data/1720420/000172042023000013/exhibit41descriptionofshar.htm)</u> to the Registrant's Annual Report on Form 10-K (File No. 001-38442), for the fiscal year ended June 30, 2023, filed with the Commission on September 13, 2023, and any amendment filed for the purpose of updating such description.

In addition, all documents that the Registrant files pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended, subsequent to the effective date of this Registration Statement, but prior to the filing of a post-effective amendment to this Registration Statement indicating that all securities offered hereby have been sold or which deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing such documents.

For purposes of this Registration Statement, any document or statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such document or statement in such document. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

------

**Item 8. Exhibits.**

---

| | |
|:---|:---|
| **EXHIBIT**<br>**NUMBER** | **DESCRIPTION** |
| <u>[4.1](https://www.sec.gov/Archives/edgar/data/1720420/000114036120016905/nt10006851x7_ex3-1.htm)</u> | <u>[Memorandum of Association (incorporated by reference to Exhibit 3.1 to the Registration Statement on Form F-1 (File No. 333-239821) as filed with the Commission on July 29, 2020).](https://www.sec.gov/Archives/edgar/data/1720420/000114036120016905/nt10006851x7_ex3-1.htm)</u> |
| <u>[4.2](https://www.sec.gov/Archives/edgar/data/1720420/000114036120023623/brhc10015867_ex1-2.htm#Exhibit:https://www.sec.gov/Archives/edgar/data/1720420/000114036120023623/brhc10015867_ex1-2.htm)</u> | <u>[Amended and Restated By-Laws (incorporated by reference to Exhibit 1.2 to the Annual Report on Form 20-F (File No. 001-38442) as filed with the Commission on October 23, 2020).](https://www.sec.gov/Archives/edgar/data/1720420/000114036120023623/brhc10015867_ex1-2.htm#Exhibit:https://www.sec.gov/Archives/edgar/data/1720420/000114036120023623/brhc10015867_ex1-2.htm)</u> |
| <u>[5.1](exhibit51ibexlimited-aswop.htm)</u> | <u>[Opinion of ASW Law Limited.](exhibit51ibexlimited-aswop.htm)</u> |
| <u>[23.1](exhibit231deloittetouchell.htm)</u> | <u>[Consent of Deloitte & Touche LLP, independent registered public accounting firm.](exhibit231deloittetouchell.htm)</u> |
| <u>[23.2](exhibit51ibexlimited-aswop.htm)</u> | <u>[Consent of ASW Law Limited (contained in Exhibit 5.1).](exhibit51ibexlimited-aswop.htm)</u> |
| <u>[24.1](#i8245cc3268204d9289eb43554b4dd3ea_108)</u> | <u>[Power of Attorney (included on signature page)](#i8245cc3268204d9289eb43554b4dd3ea_108)</u>. |
| <u>[99.1](https://www.sec.gov/Archives/edgar/data/1720420/000172042025000032/ibexlimited2025proxystatem.htm)</u> | <u>[IBEX Limited Amended and Restated 2020 Long-Term Incentive Plan (incorporated by reference to Appendix B to the Definitive Proxy Statement (File No. 001-38442) as filed with the Commission on October 28, 2025).](https://www.sec.gov/Archives/edgar/data/1720420/000172042025000032/ibexlimited2025proxystatem.htm)</u> |
| <u>[107](exhibit107-filingfeetable.htm)</u> | <u>[Filing Fee Table.](exhibit107-filingfeetable.htm)</u> |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Washington, D.C., on December 19, 2025.

**IBEX LIMITED**

By: <u>/s/ Robert Dechant</u>

Name: Robert Dechant

Title: Chief Executive Officer

------

**POWER OF ATTORNEY**

The undersigned directors and officers of IBEX Limited hereby appoint Robert Dechant and Taylor Greenwald as the true and lawful attorneys-in-fact and agents for the undersigned, with full power of substitution and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities to sign any and all amendments (including post-effective amendments) to this Registration Statement (including, without limitation, any additional registration statement filed pursuant to Rule 462 under the Securities Act of 1933), and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or would do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute and substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **<u>Name</u>** | **<u>Position</u>** | **<u>Date</u>** |
| /s/ Robert Dechant | Director and Chief Executive Officer<br>(Principal Executive Officer) | December 19, 2025 |
| Robert Dechant |  |  |
| /s/ Taylor Greenwald | Chief Financial Officer<br>(Principal Financial and Accounting Officer) | December 19, 2025 |
| Taylor Greenwald |  |  |
| /s/ Daniella Ballou-Aares | Director | December 19, 2025 |
| Daniella Ballou-Aares |  |  |
| /s/ Karen Batungbacal | Director | December 19, 2025 |
| Karen Batungbacal |  |  |
| /s/ Fiona Beck | Director | December 19, 2025 |
| Fiona Beck |  |  |
| /s/ John Jones | Director | December 19, 2025 |
| John Jones |  |  |
| /s/ Patrick McGinnis | Director | December 19, 2025 |
| Patrick McGinnis |  |  |
| /s/ Mingzhe Zhuang | Director | December 19, 2025 |
| Mingzhe Zhuang |  |  |

---

## Ex-Filing

**Exhibit 107**

**Calculation of Filing Fee Tables**

**Form S-8**

(Form Type)

**IBEX LIMITED**

(Exact Name of Registrant as Specified in its Charter)

**Table 1: Newly Registered Securities**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security Type** | **Security Class Title** | **Fee Calculation<br>Rule** | **Amount<br>Registered** | | **Proposed<br>Maximum Offering<br>Price Per Unit** | | **Maximum<br>Aggregate<br>Offering Price** | **Fee Rate** | **Amount of<br>Registration Fee** |
| Equity | Common Shares, par value $0.000111650536 | Rule 457(c)<br>and Rule 457(h) | 650000 | <sup>(1)</sup> | $37.71 | <sup>(2)</sup> | $24511500 | $0.00013810 | $3385.04 |
| **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** |  |  |  |  |  |  | $3385.04 |
| **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** |  |  |  |  |  |  |  |
| **Net Fee Due** | **Net Fee Due** | **Net Fee Due** |  |  |  |  |  |  | $3385.04 |

---

(1) Shares of common shares, $0.000111650536 par value per share ("Common Shares"), of IBEX Limited (the "Registrant") initially reserved for issuance under the IBEX Limited Amended and Restated 2020 Long-Term Incentive Plan (the "Plan") consisted of 1,987,326.13 shares registered pursuant to the registration statements on Form S-8 (File No. 333-242044 and File No. 333-263228) filed with the U.S. Securities and Exchange Commission on August 7, 2020 and March 2, 2022, respectively. Pursuant to General Instruction E on Form S-8, the registration fee is calculated with respect to the 650,000 additional Common Shares being registered on this Registration Statement on Form S-8 (this "Registration Statement") only. In addition, pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers any additional Common Shares that may become issuable pursuant to the adjustment provisions of the Plan, including as a result of any merger, amalgamation, consolidation, share rights offering, share exchange or similar event affecting the Registrant or a share dividend, share split, reverse share split, separation, spinoff, reorganization, extraordinary dividend of cash or other property, share combination or subdivision, recapitalization, capital reduction distribution, or similar event affecting the capital structure of the Registrant.

(2) Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) and (h) of the Securities Act. The proposed maximum offering price per share, proposed maximum aggregate offering price and the amount of the registration fee are based on the average of the high and low prices of Registrant's Common Shares as reported on the NASDAQ on December 16, 2025 (rounded up to the nearest cent).

## Ex-5

![aswlogo.jpg](aswlogo.jpg)

**Exhibit 5.1**

19 December 2025

Matter No.: 7570-003

+1 441 295-6500

Kim.willey@aswlaw.com<br>

IBEX Limited

Crawford House

50 Cedar Avenue

Hamilton HM 11

Bermuda

Dear Sirs/Madams,

**Re: IBEX Limited (the "Company")**

We have acted as special Bermuda legal counsel to the Company in connection with a registration statement on form S-8 filed with the Securities and Exchange Commission (the "Commission") on 19 December 2025 (the "Registration Statement", which term does not include any other document or agreement whether or not specifically referred to therein or attached as an exhibit or schedule thereto) relating to the registration under the United States Securities Act of 1933, as amended, (the "Securities Act") of 650,000 Common Shares, par value US$0.000111650536 per share (the "Common Shares"), issuable pursuant to the IBEX Limited Amended and Restated 2020 Long Term Incentive Plan which was amended and restated effective as of 5 December 2025 (the "2020 Plan", which term does not include any other document or agreement whether or not specifically referred to therein or attached as an exhibit or schedule thereto).

For the purposes of giving this opinion, we have examined copies of the Registration Statement and the 2020 Plan. We have also reviewed the memorandum of association, together with the related certificate of deposit of memorandum of increase of share capital, and the bye-laws of the Company, each certified by the Secretary of the Company on December 11<sup>th</sup>, 2025, resolutions of the Company's directors dated October 22<sup>nd</sup>, 2025 and minutes of the Company's FY25 Annual General Meeting held on December 5<sup>th</sup>, 2025 (the "Resolutions") and such other documents and made such enquiries as to questions of law as we have deemed necessary in order to render the opinion set forth below.

We have assumed (a) the genuineness and authenticity of all signatures and the conformity to the originals of all copies (whether or not certified) of all documents examined by us and the authenticity and completeness of the originals from which such copies were taken; (b) that where a document has been examined by us in draft form, it will be or has been executed and/or filed in the form of that draft, and where a number of drafts of a document have been examined by us all changes thereto have been marked or otherwise drawn to our attention; (c) the accuracy and completeness of all factual representations made in the Registration Statement, the 2020 Plan and other documents reviewed by us; (d) that the Resolutions were passed at duly convened meetings of the board and members, respectively, of the Company and remain in full force and effect and have not been rescinded or amended; (e) that there is no provision of the law of any jurisdiction, other than Bermuda, which would have any implication in relation to the opinions expressed herein; (f) that there is no provision of any Award Agreement (as defined in the Plan)

ASW Law Limited \| Crawford House \| 50 Cedar Avenue \| Hamilton HM11 \| Bermuda

PO BOX HM2879 \|Hamilton \| HMLX \| Bermuda \| T. +1 441 295 6500 \| F. +1 441 295 6566 \| W. www.aswlaw.com

------

which would have any implication in relation to the opinions expressed herein; (g) that, upon the issue of any Common Shares, the Company will receive consideration for the full issue price thereof which shall be equal to at least the par value thereof; (h) that on the date of issuance of any of the Common Shares the Company will have sufficient authorised but unissued common shares; and (i) that the Company's shares will be listed on an appointed stock exchange, as defined in the Companies Act 1981, as amended, such that approval by the Bermuda Registrar of Companies of any new beneficial owners (as such term is defined under section 2 of the Bermuda Beneficial Ownership Act 2025) of the Common Shares will not be required pursuant to section 3(2) of the Bermuda Beneficial Ownership Act 2025 at the time of issuance of any Common Shares.

We express no opinion with respect to the issuance of shares pursuant to any provision of the 2020 Plan that purports to obligate the Company to issue shares following the commencement of a winding up or liquidation. We have made no investigation of and express no opinion in relation to the laws of any jurisdiction other than Bermuda. This opinion is to be governed by and construed in accordance with the laws of Bermuda and is limited to and is given on the basis of the current law and practice in Bermuda. This opinion is issued solely for the purposes of the filing of the Registration Statement and the issuance of the Common Shares by the Company pursuant to the 2020 Plan and is not to be relied upon in respect of any other matter.

On the basis of and subject to the foregoing, we are of the opinion that:

1. The Company is duly incorporated and existing under the laws of Bermuda, and based solely on the certificate of compliance issued by the Registrar of Companies dated 11 December 2025, is in good standing (meaning solely that it has not failed to make any filing with any Bermuda government authority or to pay any Bermuda government fees or tax which would make it liable to be struck off the Register of Companies and thereby cease to exist under the laws of Bermuda).

2. When issued and paid for in accordance with the terms of the 2020 Plan, the Common Shares will be validly issued, fully paid and non-assessable (which term means when used herein that no further sums are required to be paid by the holders thereof in connection with the issue of such shares).

We consent to the filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not hereby admit that we are experts within the meaning of Section 11 of the Securities Act or that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the Commission promulgated thereunder.

Yours faithfully,

/s/ASW Law Limited

**ASW Law Limited**

![aswlawlogosmall.jpg](aswlawlogosmall.jpg)

## Ex-23

**EXHIBIT 23.1**

**<u>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</u>**

IBEX Limited

Hamilton, Bermuda

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated September 11, 2025, relating to the financial statements of IBEX Limited appearing in the Annual Report on Form 10-K of IBEX Limited for the year ended June 30, 2025.

/s/ Deloitte & Touche LLP

Deloitte & Touche LLP

Tampa, Florida

December 19, 2025

&nbsp;&nbsp;&nbsp;&nbsp;

<br>